NeOnc Technologies Acquires AI and 3D Bioprinting IP for Drug Discovery
Steady: 0 in the last 7 days
Updated nov 2
The latest in this situation
How it started
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
NeOnc Technologies Holdings, Inc. closed the acquisition of an intellectual property portfolio that includes artificial intelligence, 3D bioprinting, and quantum modeling technologies. The transaction was valued at $3.5 million, consisting of $500,000 in cash and $3 million in NeOnc common stock. The company also appointed Dr. Ishwar K. Puri to its Board.
From GlobeNewswire
Why it matters
The acquired IP allows NeOnc to create sophisticated, patient-derived 3D brain tumor models. This technology is designed to accelerate preclinical development timelines and increase the speed and accuracy of high-throughput screening for therapeutic candidates.
From GlobeNewswire
How it developed
Newest first. Tap a step to see who reported it.- Thomas Chen was appointed Chief Medical Officer at NeOnc Technologies Holdings, Inc.Sub-event
- Josh Neman was appointed Chief Clinical Officer at NeOnc Technologies Holdings, Inc.Sub-event
- Management of NeOnc Technologies Holdings, Inc. will participate in the BTIG Virtual Biotechnology Conference.Sub-event
NeOnc Technologies Holdings, Inc. advanced its drug discovery efforts through strategic partnerships and acquisitions.1 source
NeOnc appoints new officer and announces results from UAE offices.1 source
NeOnc Technologies Holdings, Inc. announced a partnership with USC's medical school.1 source
NeOnc announces strategic partnership with Quazar Investment.1 source
NeOnc Technologies Holdings, Inc. is expanding its operations into the MENA region through a strategic partnership with Quazar Investment to fund clinical trials.1 source
Coverage
Newest first; wire copies grouped- GlobeNewswireNeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board CALABASAS, Calif., Aug. 25, 2025 (GLOBE NEWSW
- GlobeNewswireNeOnc Technologies Holdings Reports Second Quarter 2025 Results and Provides Operational Update CALABASAS, Calif. and ABU DHABI, United Arab Emirates, Aug. 19, 2025 (GLOBE NEWSWIRE) -- NeOnc Technolo
- GlobeNewswireNeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia CALABASAS, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NT
- GlobeNewswireNeOnc Technologies Featured on Yahoo Finance's Podcast Trader Talk: AI and Biotech Take on Brain Cancer CALABASAS, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ:
- GlobeNewswireNeOnc Technologies Signs Definitive Agreement to Acquire AI, 3D, and Quantum Modeling IP Portfolio from Dr. Ishwar K. Puri; Appoints Him to Board of Directors CALABASAS, Calif., July 30, 2025 (GLOBE
- GlobeNewswireNeOnc Technologies Signs Definitive Agreement for $50 Million Strategic Partnership with Quazar Investment CALABASAS, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASD
- GlobeNewswireNeOnc Technologies Executes Sub-License Agreement, Marking Key Milestone Toward Closing $50 Million Strategic Partnership with Quazar Investment CALABASAS, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- N
- GlobeNewswireNeOnc Technologies Secures Board Approval for $50 Million Strategic Partnership with Quazar Investment CALABASAS, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: